BioCentury
ARTICLE | Clinical News

Pimagedine: Began a Phase II/III trial in 660 patients

February 22, 1994 8:00 AM UTC

Alteon Inc. (ALTN), Northvale, N.J. Product: Pimagedine (formerly aminoguanidine) Indication: Diabetic patients who have shown progression of kidney disease Status: Began a Phase II/III trial in 660 p...